On 12 March 2026, China Medical System Holdings Limited ('CMS” or the 'Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited ('Dermavon”, an innovative pharmaceutical company ...
New research ties glyphosate–metal mixtures to possible kidney damage and a key safety study is retracted, raising concerns for heavy users.